Innovative care delivery programs intended to improve quality and reduce costs need sustainable business models in order to last beyond the end of grants or other methods of time-limited funding. RAND researchers take a look at methods Massachusetts health plans and accountable care organizations are using.
Payers and providers using new payment methods to align financial incentives with quality improvement and cost reduction goals may be relying on grants or related funding methods to test pilots; however, these only provide time-limited support. These programs must have a sustainable business model if they are to last beyond the end of grant funding, according to a study from RAND Corporation.
The researchers used a sample of 7 health plans and 5 accountable care organizations (ACOs) in Massachusetts to identify paths to sustainability for innovate care delivery programs.
“Dynamics in the current environment suggest that innovation will likely be concentrated in health care delivery systems that are able to manage financial risk and that have experience and capacity in delivery innovation,” the authors wrote. “For providers seeking to innovate, the central challenge will be building the capacity to manage financial risk in global payment arrangements and to support improvements in care.”
Among the health plans and ACOs studied, the most common short-term objective of innovative care delivery programs intended to improve quality and reduce costs was to improve the coordination of care for the highest-risk patients.
The 2 criteria most often used by study participants to assess innovative care delivery programs are scale and impact, which depend on the number of relevant and affected patients as well as the potential for improvement in quality and reductions in healthcare costs for the population.
In addition, the researchers found that while savings can be a potentially important factor when determining which care delivery program to invest in, the program does not have to demonstrate cost savings in a pilot prior to investment.
Study participants indicated that the healthcare payment environment still needs to shift farther from fee-for-service in order to meaningfully support care delivery innovation. Respondents also highlighted a lack of alignment across payers and care delivery programs. Lastly, they suggested a better understanding of the costs and effects of care delivery transformation is still needed.
“We found widespread interest and activity in testing new care delivery models to improve health care quality and reduce costs in Massachusetts,” the authors concluded. “However, the environment presents great uncertainty for the sustainability of these programs.”
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Tailored Dosing for MM Matters More Than Drug Count: Ajai Chari, MD
April 25th 2025When it comes to treating multiple myeloma (MM), Ajai Chari, MD, argued that more is not always better. More intense treatment regimens, or those with more drugs, don't necessarily guarantee better outcomes.
Read More
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
Top Pharmacy Leaders to Convene at Asembia’s AXS25 Summit in Las Vegas
April 24th 2025Asembia's AXS25 Summit will unite more than 8000 key decision-makers to explore pharmacy innovation, artificial intelligence, policy, and patient care from April 27 to May 1 at Wynn & Encore in Las Vegas, Nevada.
Read More